Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
Alzheimer's disease (AD) is a neurodegenerative disease that is clinically characterized by progressive cognitive decline. More than 200 pathogenic mutations have been identified in amyloid-β precursor protein (APP), presenilin 1 (PSEN1) and presenilin 2 (PSEN2). Additionally, common and rare v...
Main Authors: | Simon Hsu, Anna A. Pimenova, Kimberly Hayes, Juan A. Villa, Matthew J. Rosene, Madhavi Jere, Alison M. Goate, Celeste M. Karch |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996120300929 |
Similar Items
-
APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines
by: Xuewen Xiao, et al.
Published: (2021-06-01) -
Discovery and validation of autosomal dominant Alzheimer’s disease mutations
by: Simon Hsu, et al.
Published: (2018-07-01) -
Alterações genéticas na doença de Alzheimer
by: Cintia Fridman, et al.
Published: (2004-01-01) -
A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer’s disease
by: Vo Van Giau, et al.
Published: (2019-08-01) -
Evaluation of PSEN1 subunit of the γ-secretase gene in patients with psoriasis vulgaris: a pilot study
by: Beata Bergler-Czop, et al.
Published: (2021-01-01)